nifedipine has been researched along with cgp 28392 in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (70.00) | 18.7374 |
| 1990's | 8 (26.67) | 18.2507 |
| 2000's | 1 (3.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gainullin, R; Saxon, M | 1 |
| Bolger, GT; Campbell, N; Crowley, M; McKay, DW; O'Neill, SK; Triggle, CR | 1 |
| Frank, GB | 1 |
| Alonso, MJ; Marín, J; Rico, I; Salaices, M | 2 |
| Akimoto, T; Ariyoshi, S; Fujisue, T; Ichida, S; Wada, T | 1 |
| Marinov, BS; Saxon, ME | 1 |
| Brooks, HL; Gross, GJ; Preuss, KC; Warltier, DC | 1 |
| Affolter, H; Coronado, R | 1 |
| Brill, DM; Fozzard, HA | 1 |
| Criscione, L; Meier, M; Rogg, H; Truog, A | 1 |
| Schramm, M; Towart, R | 1 |
| Jakobsen, P; Mikkelsen, EO; Nyborg, NC | 1 |
| Carpenter, CL; Greenberg, DA; Messing, RO | 1 |
| Matsumura, Y; Morimoto, S; Sasaki, Y; Shinyama, H; Uriu, T | 1 |
| Malaisse, WJ; Malaisse-Lagae, F; Sener, A | 1 |
| Dubur, GIa; Ivakhniuk, IS; Shvinka, NE; Skrastyn'sh, IP; Velena, AKh | 1 |
| Montague, W; Morgan, NG; Rumford, GM; Short, CD | 1 |
| Bühler, FR; Erne, P; Resink, TJ | 1 |
| Kamp, TJ; Miller, RJ; Sanguinetti, MC | 1 |
| Groth, H; Locher, R; Neyses, L; Stimpel, M; Vetter, W | 1 |
| Kokubun, S; Reuter, H | 1 |
| Freedman, SB; Miller, RJ | 1 |
| Lazdunski, M; Méaux, JP; Renaud, JF; Romey, G; Schmid, A | 1 |
| Hof, A; Hof, RP; Loutzenhiser, R; Rüegg, UT | 1 |
| Bühler, FR; Bürgisser, E; Dubach, B; Erne, P; Kühnis, H; Meier, M; Rogg, H | 1 |
| Krieger, A | 1 |
| Chaylakhyan, LM; Grishchenko, VM; Zherelova, OM | 1 |
| Kanno, M; Nakaya, H; Takeda, Y; Tohse, N | 1 |
| Brochu, M; Cadorette, C; Poterek, M; Simaan, M; St-Louis, J | 1 |
2 review(s) available for nifedipine and cgp 28392
| Article | Year |
|---|---|
Slow channel calcium activators, a new group of pharmacological agents.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Blood Pressure; Calcium; Calcium Channel Blockers; Cells, Cultured; Heart; Heart Rate; Ion Channels; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Pyridines; Stimulation, Chemical; Vascular Resistance | 1985 |
Modulation of calcium channel function by drugs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Dihydropyridines; Electric Conductivity; Heart Rate; Homeostasis; Humans; Ion Channels; Membrane Potentials; Nifedipine; Pyridines; Receptors, Cell Surface; Structure-Activity Relationship | 1985 |
28 other study(ies) available for nifedipine and cgp 28392
| Article | Year |
|---|---|
Two subtypes of dihydropyridine-sensitive calcium channels in rat ventricular muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Calcium Channel Agonists; Calcium Channels; Dihydropyridines; Female; Heart; In Vitro Techniques; Magnesium; Male; Myocardial Contraction; Myocardium; Nifedipine; Potassium Chloride; Pyridines; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum | 1990 |
Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Calcium Channel Agonists; Catecholamines; Chromatography, High Pressure Liquid; Dihydropyridines; Guinea Pigs; Injections, Intraperitoneal; Male; Mice; Motor Activity; Muscle Contraction; Muscle, Smooth; Nicotinic Acids; Nifedipine; Oxadiazoles; Pyridines; Stereoisomerism; Structure-Activity Relationship | 1990 |
Dihydropyridine calcium channel antagonists block and agonists potentiate high potassium contractures but not twitches in frog skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Muscle Contraction; Nifedipine; Nitrendipine; Potassium; Pyridines; Rana pipiens | 1990 |
Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Female; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Potassium; Pyridines; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Effects of calcium channel agonists (BAY K 8644, CGP28392 and YC-170) on 45Ca uptake by rat uterine segments.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Female; Nifedipine; Nitrendipine; Potassium Chloride; Pyridines; Rats; Rats, Inbred Strains; Uterus | 1991 |
Dihydropyridine Ca2+ agonists and channel blockers interact in the opposite manner with photogenerated unpaired electrons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Electron Transport; Eosine Yellowish-(YS); Heme; Ion Channels; Kinetics; Myoglobin; Nifedipine; Pyridines; Structure-Activity Relationship; Whales | 1985 |
Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Electric Conductivity; Ion Channels; Kinetics; Muscles; Nifedipine; Pyridines | 1985 |
Calcium channel blocking drugs. Part I: The calcium channel.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Biological Transport, Active; Calcium; Calcium Channel Blockers; Cell Membrane Permeability; Electric Conductivity; Humans; Ion Channels; Muscle, Smooth; Muscle, Smooth, Vascular; Muscles; Nifedipine; Pyridines | 1985 |
In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding, Competitive; Biological Transport; Calcium; Guinea Pigs; Heart Rate; In Vitro Techniques; Ion Channels; Male; Mesentery; Myocardial Contraction; Nifedipine; Nitrendipine; Pyridines; Rats; Vasoconstriction | 1985 |
A comparison of effects of BAY K 8644 and CGP 28392, dihydropyridines with Ca agonistic properties, on spontaneous mechanical activity in rat portal vein: modification of effect by ultraviolet radiation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Portal Vein; Pyridines; Rats; Rats, Inbred WKY; Ultraviolet Rays | 1985 |
Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Cells, Cultured; Isradipine; Kinetics; Membrane Potentials; Nifedipine; Nitrendipine; Onium Compounds; Organophosphorus Compounds; Oxadiazoles; Potassium; Pyridines; Tritium | 1986 |
Inhibitory effects of calcium channel agonists on renin release from rat kidney cortical slices.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Dose-Response Relationship, Drug; Imidazoles; Ion Channels; Kidney Cortex; Male; Nifedipine; Pyridines; Rats; Rats, Inbred Strains; Renin; Trifluoperazine; Verapamil | 1987 |
Stimulation of insulin release by organic calcium-agonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Ion Channels; Islets of Langerhans; Kinetics; Nifedipine; Pyridines | 1986 |
Effects of the Ca agonists Bay K 8644 and CGP 28392 on vascular smooth muscle tone.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Calcium; Calcium Channel Agonists; Calcium Channels; Calcium Radioisotopes; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Nifedipine; Pyridines; Rats; Rats, Inbred Strains | 1989 |
[The effect of dihydropyridines on the strontium and calcium content in frog muscle].
Topics: Animals; Calcium; Dihydropyridines; In Vitro Techniques; Isotonic Solutions; Muscles; Nifedipine; Pyridines; Rana temporaria; Ringer's Solution; Strontium | 1989 |
Effects of the calcium-channel agonist CGP 28392 on insulin secretion from isolated rat islets of Langerhans.
Topics: Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nifedipine; Nitrendipine; Norepinephrine; Pyridines; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1985 |
The influence of CGP 28392, a 1,4-dihydropyridine, on human platelet calcium and cyclic AMP metabolism.
Topics: Alprostadil; Blood Platelets; Calcium; Calcium Channel Blockers; Cyclic AMP; Humans; In Vitro Techniques; Kinetics; Nifedipine; Nitrendipine; Phosphorylation; Protein Kinases; Pyridines | 1985 |
Stimulation rate modulates effects of the dihydropyridine CGP 28 392 on cardiac calcium-dependent action potentials.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Electric Stimulation; Female; Guinea Pigs; Kinetics; Male; Nifedipine; Papillary Muscles; Potassium; Pyridines | 1985 |
Human red blood cells--an ideal model system for the action of calcium agonists and antagonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Erythrocytes; Humans; Ion Channels; Nicardipine; Nifedipine; Nitrendipine; Pyridines; Stimulation, Chemical; Verapamil | 1984 |
Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Cells, Cultured; Heart; Ion Channels; Kinetics; Nifedipine; Pyridines; Rats | 1984 |
Calcium channel activation: a different type of drug action.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Cadmium; Calcium; Calcium Channel Blockers; Cell Line; Diltiazem; Gallopamil; Glioma; Hybrid Cells; Ion Channels; Kinetics; Mice; Neuroblastoma; Nifedipine; Nitrendipine; Pyridines; Rats | 1984 |
Activation of the voltage-dependent Ca2+ channel in rat heart cells by dihydropyridine derivatives.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bepridil; Calcium; Dose-Response Relationship, Drug; Ion Channels; Myocardium; Nifedipine; Pyridines; Pyrrolidines; Rats; Rats, Inbred Strains; Time Factors; Verapamil | 1984 |
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Nifedipine; Potassium Chloride; Pyridines; Rabbits; Vasoconstriction; Vasoconstrictor Agents | 1984 |
Enhancement of calcium influx in human platelets by CGP 28392, a novel dihydropyridine.
Topics: Animals; Blood Platelets; Calcium; Calcium Channel Blockers; Cell Membrane; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Ion Channels; Myocardium; Nifedipine; Nitrendipine; Pyridines | 1984 |
Effect of the Ca2+ channel activator CGP 28392 on reactivation of oxygen evolution of Ca(2+)-depleted photosystem II.
Topics: Calcium; Calcium Channel Agonists; Calcium Chloride; Hydrogen-Ion Concentration; Nifedipine; Oxygen; Photosynthetic Reaction Center Complex Proteins; Photosystem II Protein Complex; Pyridines; Verapamil | 1995 |
Blockers of Ca2+ channels in the plasmalemma of perfused Characeae cells.
Topics: Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cell Membrane; Chlorophyta; Dihydropyridines; Membrane Potentials; Nifedipine; Nitrendipine; Perfusion; Pyridines | 1994 |
Voltage-dependence of Ca2+ agonist effect of YC-170 on cardiac L-type Ca2+ channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channels; Heart; Myocardium; Nifedipine; Patch-Clamp Techniques; Pyridines; Rabbits | 1995 |
Calcium channels contribute to the decrease in blood pressure of pregnant rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Pressure; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Female; Hypotension; Male; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Pyridines; Rats; Rats, Sprague-Dawley | 2002 |